Suspecting and Diagnosing ATTR Amyloidosis
Morie A Gertz, MD, MACP
Consultant – Division of Hematology, Department of Internal Medicine
Professor of Medicine
Mayo Clinic College of Medicine and Science
The target audience for this initiative is physicians and other providers, including nurse practitioners and physician assistants, who may encounter patients in their practice with undiagnosed amyloid transthyretin (ATTR) amyloidosis.